1 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 470 of 3750 | 1460 prescriptions Less than 1% of all prescriptions | 1340 | 430 patients 14% of all patients | < 11 | |
2 MONTELUKAST SODIUM | 1340 of 4500 | 1160 prescriptions Less than 1% of all prescriptions | 940 | 230 patients 8% of all patients | < 11 | |
3 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 1360 of 4230 | 920 prescriptions Less than 1% of all prescriptions | | 280 patients 9% of all patients | < 11 | |
4 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 110 of 1840 | 940 prescriptions Less than 1% of all prescriptions | 940 | 220 patients 7% of all patients | 220 patients 7% of all patients | |
5 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 600 of 3370 | 820 prescriptions Less than 1% of all prescriptions | 700 | 200 patients 7% of all patients | < 11 | |
6 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 1620 of 4560 | 580 prescriptions Less than 1% of all prescriptions | 400 | 200 patients 7% of all patients | < 11 | |
7 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 940 of 4380 | 640 prescriptions Less than 1% of all prescriptions | 500 | 170 patients 6% of all patients | < 11 | |
8 PROAIR HFA (ALBUTEROL SULFATE) | 980 of 4320 | 690 prescriptions Less than 1% of all prescriptions | 570 | 370 patients 12% of all patients | < 11 | |
9 PREDNISONE | 1000 of 4670 | 1460 prescriptions Less than 1% of all prescriptions | 1190 | 890 patients 29% of all patients | 740 patients 24% of all patients | |
10 DALIRESP (ROFLUMILAST) | 520 of 1740 | 260 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
11 VENTOLIN HFA (ALBUTEROL SULFATE) | 1130 of 4490 | 640 prescriptions Less than 1% of all prescriptions | 400 | 320 patients 10% of all patients | < 11 | |
12 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 340 of 2150 | 510 prescriptions Less than 1% of all prescriptions | | 170 patients 6% of all patients | < 11 | |
13 SPIRIVA (TIOTROPIUM BROMIDE) | 1080 of 4040 | 380 prescriptions Less than 1% of all prescriptions | | 110 patients 4% of all patients | < 11 | |
14 FLUTICASONE PROPIONATE | 970 of 3510 | 280 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 BEVESPI AEROSPHERE (GLYCOPYRROLATE/FORMOTEROL FUM) | 170 of 930 | 300 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 ZOLPIDEM TARTRATE | 340 of 1280 | 300 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
17 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 490 of 2130 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 250 of 1300 | 310 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 430 of 1250 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 TEMAZEPAM | 250 of 550 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 OFEV (NINTEDANIB ESYLATE) | 360 of 1150 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
22 DOXYCYCLINE HYCLATE | 200 of 1340 | 550 prescriptions Less than 1% of all prescriptions | | 490 patients 16% of all patients | < 11 | A |
23 IPRATROPIUM BROMIDE | 390 of 1020 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 1330 of 3700 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 DULERA (MOMETASONE/FORMOTEROL) | 230 of 850 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 FLUTICASONE-SALMETEROL (FLUTICASONE PROPION/SALMETEROL) | 200 of 320 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
27 CEFUROXIME (CEFUROXIME AXETIL) | 160 of 360 | 190 prescriptions Less than 1% of all prescriptions | | 190 patients 6% of all patients | < 11 | A |
28 AZITHROMYCIN | 1100 of 3840 | 340 prescriptions Less than 1% of all prescriptions | | 280 patients 9% of all patients | < 11 | A |
29 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 450 of 1570 | 160 prescriptions Less than 1% of all prescriptions | | 150 patients 5% of all patients | < 11 | A |